[1]钟传棋 吴斌△ 杨功旭 张清 金军.伤疼巴布贴治疗早中期膝骨关节炎的临床研究[J].中国中医骨伤科杂志,2021,29(04):35-38.
　ZHONG Chuanqi WU Bin YANG Gongxu ZHANG Qing JIN Jun.Observation of Clinical Efficacy of Shangteng Cataplasm onEarly and Mid-Stage Knee Osteoarthritis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2021,29(04):35-38.
点击复制

伤疼巴布贴治疗早中期膝骨关节炎的临床研究()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第29卷
期数:
2021年04期
页码:
35-38
栏目:
临床研究
出版日期:
2021-04-15

文章信息/Info

Title:
Observation of Clinical Efficacy of Shangteng Cataplasm onEarly and Mid-Stage Knee Osteoarthritis
文章编号:
1005-0205(2021)04-0035-04
作者:
钟传棋1; 2 吴斌1; 2△ 杨功旭1; 2 张清1; 2 金军1; 2
1湖北省中医院(武汉,430061)
2湖北省中医药研究院
Author(s):
ZHONG Chuanqi1; 2 WU Bin1; 2△ YANG Gongxu1; 2 ZHANG Qing1; 2 JIN Jun1; 2
1Hubei Provincial Hospital of Traditional Chinese Medicine,Wuhan 430061,China; 2Hubei Province Academy of Traditional Chinese Medicine,Wuhan 430074,China.
关键词:
伤疼巴布贴;  膝关节;  骨性关节炎;  基质金属蛋白酶-13;  白介素-1β
Keywords:
Shangteng cataplasm;  knee;  osteoarthritis;  matrix metalloproteinase-13;  interleukin-1β
分类号:
R684.3
文献标志码:
A
摘要:
目的:探讨伤疼巴布贴对早中期膝骨关节炎的临床疗效及对患者外周血清中MMP-13和IL-1β的影响。方法:选择早中期膝骨关节炎患者80例,随机编码分为观察组和对照组治疗,每组各40例,对照组外用双氯芬酸钠贴剂治疗,观察组外用伤疼巴布贴治疗,治疗2周,观察治疗前后VAS评分、WOMAC指数及Lysholm膝关节评分变化,ELISA法测定治疗前后患者外周血清中MMP-13及IL-1β变化。结果:治疗期间两组无皮肤过敏等情况,对照组VAS评分及WOMAC指数治疗前后比较差异有统计学意义(P<0.05),观察组VAS评分、WOMAC指数及Lysholm膝关节评分治疗前后比较差异有统计学意义(P<0.05); 组间比较,治疗后两组WOMAC指数及Lysholm膝关节评分差异有统计学意义(P<0.05); 观察组治疗前后外周血清中MMP-13和IL-1β差异有统计学意义(P<0.05),治疗后组间IL-1β水平比较差异有统计学意义(P<0.05)。结论:伤疼巴布贴治疗早中期膝骨关节炎能较好减轻疼痛、改善症状,伤疼巴布贴治疗骨关节炎可能与降低MMP-13和IL-1β水平相关。
Abstract:
To explore the clinical effect of Shangteng Cataplasm on early and mid-stage knee osteoarthritis and its influence on MMP-13 and IL-1β in peripheral serum of patients.Methods:Eighty patients with knee osteoarthritis were selected and randomly divided into observation and control group for treatment with 40 cases in each group.The control group was treated with diclofenac sodium patch,and the observation group was treated with Shangteng Cataplasm.VAS score,WOMAC index,Lysholm knee joint score before and after treatment were documented after 2 weeks’ treatment.MMP-13 and IL-1β in peripheral serum of patients before and after treatment were measured by ELISA.Results:Two groups revealed no skin allergies during the treatment period.Statistically significants of VAS score and WOMAC index were founded in control group before and after treatment(P<0.05).Statistically significants of VAS score,WOMAC index,and Lysholm knee joint score were founded in observation group before and after treatment(P<0.05).There were difference in WOMAC index and Lysholm knee score between the two groups(P<0.05).there were statistical differences in serum MMP-13 and IL-1β of the observation group before and after treatment(P<0.05).Conclusion:Shangteng cataplasm for knee osteoarthritis in early and mid-stage knee osteoarthritis can effectively relieve pain and improve symptoms,which may be related to the reduction of MMP-13 and IL-1β.

参考文献/References:

[1] 中华医学会骨科学分会关节外科学组.骨关节炎诊疗指南(2018年版)[J].中华骨科杂志,2018,38(12):705-715.
[2] 中华中医药学会.中医骨伤科临床诊疗指南·膝痹病(膝骨关节炎)[J].康复学报,2019,29(3):1-7.
[3] 张洪美.膝骨关节炎的规范诊治与阶梯治疗[J].中国骨伤,2019,32(5):391-395.
[4] 苏友新,黄露露,赖兴泉,等.飞龙九一巴布贴抗炎、镇痛药效学及其对膝骨关节炎滑膜炎影响的研究[J].风湿病与关节炎,2019,8(1):5-9.
[5] 杨佳生,卢彬,吴佳芳,等.西关正骨巴布剂穴位贴敷治疗骨质疏松性椎体压缩骨折术后便秘疗效观察[J].按摩与康复医学,2020,11(2):59-60.
[6] 中华医学会骨科学分会.骨关节炎诊治指南(2007年版)[J].中国矫形外科杂志,2014,22(3):287-288.
[7] BELLAMY N.Pain assessment in osteoarthritis:experience with the WOMAC osteoarthritis index[J].Semin Arthritis Rheum,1989,18(4 Suppl 2):14-17.
[8] LYSHOLM J,GILLQUIST J.Evaluation of knee ligament surgery results wits special emphasis on use of a scoring scale[J].Am J Sports Med,1982,10(3):150-154.
[9] 王弘德,李升,陈伟,等.《骨关节炎诊疗指南(2018年版)》膝关节骨关节炎部分的更新与解读[J].河北医科大学学报,2019,40(9):993-995.
[10] HAWKER G A,CROXFORD R,BIERMAN A S,et al.All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis:a population based cohort study[J].PLoS ONE,2014,9(3):e91286.
[11] LIU Q,NIU J,LI H,et al.Knee symptomatic osteoarthritis,walking disability,NSAIDs use and ALL-cause mortality:population-based wuchuan osteoarthritis study[J].Sci Rep,2017,7(1):3309-3315.
[12] 蔡卓亚,周自桂,李萍,等.伸筋草化学成分及药理作用研究进展[J].中草药,2015,46(2):297-304.
[13] 艳杰,王丽娜.伸筋草配方颗粒的药理等效性实验研究[J].长春中医药大学学报,2014,30(3):403-404.
[14] 刘静,年华,徐熠,等.伸筋草生物碱对佐剂性关节炎大鼠的抗炎作用及机制研究[J].药物评价研究,2019,42(5):869-872.
[15] 侯文斌,韦嵩.南星骨痛凝胶贴膏对兔膝骨关节炎关节形态及血清IL-1、TNF-α、MMP-13、TIMP-1表达的影响[J].辽宁中医杂志,2020,47(2):184-187.
[16] 王晶,陈心怡,蒋沁悦,等.土鳖虫水提物对MC3T3-E1、PC12、HUVEC细胞增殖及 H2O2 损伤修复的影响[J].中南药学,2020,18(4):587-590.
[17] 匡剑韧,蒋毅,邹庆华.土茯苓单味辅助治疗湿热蕴结型急性痛风性关节炎临床疗效[J].临床合理用药,2020,17(7A):18-20.
[18] 钟传棋,杨功旭,戴政文,等.健骨方对早中期膝骨关节炎患者MMP-13、TIMP1及IL-1β的影响[J].中国中医基础医学杂志,2018,24(12):1727-1729.
[19] WANG M, SAMPSON E R, JIN H,et al.MMP13 is a critical target gene during the progression of osteoarthritis[J].Arthritis Res Ther,2013,15(1):R5.
[20] LI H, WANG D, YUAN Y,et al.New insights on the MMP-13 regulatorynetwork in the pathogenesis of early osteoarthritis[J].Arthritis Res Ther,2017,19(1):248-255.
[21] SEIDL C I, FULGA T A, MURPHY C L.CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type Ⅱ collagen accumulation[J].Osteoarthritis Cartilage,2019,27(1):140-147.

备注/Memo

备注/Memo:
基金项目:湖北省自然科学基金面上项目(2017CFC836)湖北省中医院“五专建设”项目
△通信作者 E-mail:13707176057@139.com
更新日期/Last Update: 2021-04-15